pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
PL-18
Bacterial Vaginosis
Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
0
catalysts
Phase 2
PL-8177
Ulcerative Colitis
$PTNT
PALATIN TECHNOLOGIES INC
0
catalysts
Phase 2
PM-359
Chronic Granulomatous Disease
$PRME
Prime Medicine, Inc.
0
catalysts
Phase 2
PMD-026
← prev
page 22 of 50
next →
131
Pain
89
Neurology
1
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Phoenix Molecular Designs
0
catalysts
Phase 2
PORT-77
Erythropoietic Protoporphyria
GondolaBio LLC
0
catalysts
Phase 2
PR-001
Parkinson's Disease
Prevail Therapeutics Inc
0
catalysts
Phase 2
PR-15
Stroke
advanceCor GmbH
0
catalysts
Phase 2
PRGN-2009
Anal Cancer
$PGEN
PRECIGEN, INC.
0
catalysts
Phase 2
PRL3-ZUMAB
Solid Tumor
IISG Pte Ltd
0
catalysts
Phase 2
PRX-115
Gouty Arthritis (Gout)
$PLX
Protalix BioTherapeutics, Inc.
0
catalysts
Phase 2
PS-002
IgA Nephropathy (Berger's Disease)
Purespring Therapeutics Ltd
0
catalysts
Phase 2
PSV-359
Solid Tumor
$CATX
Perspective Therapeutics, Inc.
0
catalysts
Phase 2
PT-00114
Generalized Anxiety Disorder (GAD)
Protagenic Therapeutics Inc
0
catalysts
Phase 2
PTT-936
Solid Tumor
Pyrotech (Beijing) Biotechnology Co Ltd
0
catalysts
Phase 2
PTX-100
Cutaneous T-Cell Lymphoma
Prescient Therapeutics Ltd
0
catalysts
Phase 2
PTX-9908
Hepatocellular Carcinoma
C-X-C chemokine receptor type 4
Pertinax Therapeutics Inc
0
catalysts
Phase 2
PVX-108
Peanut Allergy
Aravax Pty Ltd
0
catalysts
Phase 2
PVX-7
Human Papillomavirus (HPV) Associated Cancer
PapiVax Biotech Inc
0
catalysts
Phase 2
PXL-065
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Poxel SA
0
catalysts
Phase 2
Panaecin
Panaecintm (gallium citrate)
Chronic Lung Infection
Aridis Pharmaceuticals Inc
0
catalysts
Phase 2
Parathyroid Hormone Inverse Agonist (PTH-IA)
Mutational Disorders
National Center for Advancing Transitional Sciences
0
catalysts
Phase 2
Peanut SLIT-tablet
Peanut Allergy
ALK-Abello AS
0
catalysts
Phase 2
Pneumostem
Bronchopulmonary Dysplasia
MediPost Co Ltd
0
catalysts
Phase 2
PolyPEPI-1018
Metastatic Colorectal Cancer
Treos Bio Ltd
0
catalysts
Phase 2
ProLectin-M
Coronavirus Disease 2019 (COVID-19)
$BIXT
BIOXYTRAN, INC
0
catalysts
Phase 2
QBS-10072S
Glioblastoma Multiforme (GBM)
Quadriga BioSciences Inc
0
catalysts
Phase 2
QT-019B
Systemic Lupus Erythematosus
Hangzhou Qihan Biotechnology Co Ltd
0
catalysts
Phase 2
QTP-101
Tuberculosis
Quratis Inc
0
catalysts
Phase 2
R-289
Myelodysplastic Syndrome (Preleukemia)
$RIGL
RIGEL PHARMACEUTICALS INC
0
catalysts
Phase 2
R-327
Urinary Tract Infections
Recce Pharmaceuticals Ltd
0
catalysts
